Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07786025 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07786025 · ClinicalTrials.gov record · last posted 2026-08-25

DisTal Arterio-Venous Fistula Feasibility

Study acronym: DisTal
StatusActive, Not Recruiting
PhaseNot applicable
Started2024-12-02
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this clinical trial is to evaluate, in a clinical setting, the feasibility of vein enlargement at the site of the arteriovenous fistula created percutaneously, using the DisTal device ("DisTal AVF"). The main question the study aims to answer is what is the rate of successful enlargement of the vein at the site of DisTal AVF within 100 days of the procedure, as confirmed by ultrasound.
Trial Details
NCT Number NCT07786025
Lead Sponsor Distal Inc.
Conditions End-Stage Renal Disease Requiring Haemodialysis
Enrollment 100 participants
Start Date 2024-12-02
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-25